A biotech spinout company from the University of Exeter, founded in 2020 and dedicated to the development of new approaches to reverse cellular senescence.
Have developed and brought to market the first commercial, fully integrated brain imaging device based on optically pumped magnetometers.
Developing breakthrough cancer treatments that target DNA Damage Response pathways to specifically destroy certain devastating cancers that are difficult to treat.
A global health technology firm which provides autonomous echocardiography analysis through innovative AI solutions.
Most Transformative Digital Healthcare Company, Kindly Sponsored by Ipsen
Collaborates with life science companies and health systems to create a trusted data community, deriving insights from analysing large, complex data sets of anonymised and de-identified patient data.
Have created an AI data discovery platform that enables Biotech, Pharma and CROs to identify high-value drug targets and biomarkers, validate state-of-the-art algorithms and get new products to the market more quickly.
Provide integrated Pharmaceutical Development and Clinical Pharmacology services and consultancy to the Pharma and Biotechnology Industry.
Most Impactful Business Support Organisation
Encompass both a research institute and a global outreach programme, which aims to transform pioneering science into therapies.
Most Impactful UK Deal, Kindly Sponsored by GenScript
Played a key role in the manufacturing of the AstraZeneca COVID-19 vaccine which saw the production of the vaccine achieved at unprecedented scale and pace.
Best Established Medtech Company, Kindly sponsored by Milton Park
A world leading digital healthcare company which has developed a comprehensive, scalable and simple-to-use advanced patient monitoring platform - the Patient Status Engine
A clinical-stage immuno-oncology company, with a first-in-class lead programme and a pipeline of additional T cell enhancing therapeutics
Clive Dix, CEO of C4X Discovery, Chairman of Centauri Therapeutics, and Non-Executive Director of the Medicines Discovery Catapult and until April 2021, Interim Chair of the UK Vaccine Taskforce.
In recognition of his extensive achievements within the UK biotechnology industry and with many biotechs over more than 30 years.
Congratulations to all our winners.
The OBN team